Semi-LASER 1 H MR spectroscopy at 7 Tesla in human brain: Metabolite quantification incorporating subject-specific macromolecule removal

Magn Reson Med. 2015 Jul;74(1):4-12. doi: 10.1002/mrm.25380. Epub 2014 Jul 31.

Abstract

Purpose: To develop an in vivo 1 H short-echo-time semi-LASER spectroscopy protocol at 7 Tesla (T) incorporating subject-specific macromolecule removal.

Methods: T1 constants of the major metabolites were measured with little macromolecule contribution in seven healthy volunteers and used to optimize double inversion metabolite nulling. Spectra were acquired from parietal-occipital cortex of five healthy volunteers. Metabolite-nulled macromolecule spectra were subtracted from the metabolite spectra before fitting in the time domain with prior-knowledge templates. Absolute metabolite concentrations were determined by referencing to the water signal, following partial volume and relaxation corrections.

Results: The average signal to noise ratio, N-acetylaspartate peak height divided by the baseline noise standard deviation, was 48 ± 6. T1 constants for N-acetylaspartate, glutamate, creatine, and choline were 1.71 ± 0.15 s, 1.68 ± 0.19 s, 1.63 ± 0.10 s, and 1.41 ± 0.09 s, respectively. The optimal double inversion times for metabolite suppression were TI1 = 2.09 s and TI2 = 0.52 s. The coefficient of variation was less than 10% for N-acetylaspartate, creatine, choline, and myo-inositol, and less than 20% for glutamate and glutamine.

Conclusion: Short echo-time 1 H semi-LASER spectroscopy at 7T incorporating subject-specific macromolecule removal yielded reproducible brain metabolite concentrations ideal for applications in disease conditions where macromolecule contributions may deviate from the norm. Magn Reson Med 74:4-12, 2015. © 2014 Wiley Periodicals, Inc.

Keywords: 7T; LASER; MRS, quantification; high magnetic field; human brain; macromolecule; magnetic resonance spectroscopy; semi-LASER; short echo time.